SIRT1 in neurodevelopment and brain senescence - PubMed (original) (raw)

Review

SIRT1 in neurodevelopment and brain senescence

A Zara Herskovits et al. Neuron. 2014.

Abstract

Sirtuins are nicotinamide adenine dinucleotide (NAD+)-dependent deacylases that have traditionally been linked with calorie restriction and aging in mammals. These proteins also play an important role in maintaining neuronal health during aging. During neuronal development, the SIR2 ortholog SIRT1 is structurally important, promoting axonal elongation, neurite outgrowth, and dendritic branching. This sirtuin also plays a role in memory formation by modulating synaptic plasticity. Hypothalamic functions that affect feeding behavior, endocrine function, and circadian rhythmicity are all regulated by SIRT1. Finally, SIRT1 plays protective roles in several neurodegenerative diseases including Alzheimer's, Parkinson's, and motor neuron diseases, which may relate to its functions in metabolism, stress resistance, and genomic stability. Drugs that activate SIRT1 may offer a promising approach to treat these disorders.

Copyright © 2014 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1. The influence of sirtuin 1 on neuronal architecture. The role of SIRT1 on structural features of neuronal cells are depicted

SIRT1 can promote axon development by deacetylating Akt and inhibiting Gsk3 affecting microtubule dynamics during axon elongation (Li et al., 2013). SIRT1 also interacts with microRNA-138 via a negative feedback loop and this microRNA suppresses axon growth (Liu et al., 2013). SIRT1 also affects dendritic arborization (Michan et al., 2010) and dendritic spine morphology by inhibition of ROCK kinase activity (Ferrante et al., 1997). Cytoplasmic SIRT1 can stimulate NGF-dependent neurite outgrowth (Hisahara et al., 2008; Sugino et al., 2010), which is due to downregulation of mTOR and inhibition of its downstream effectors (Guo et al., 2011).

Figure 2

Figure 2. The regulation of learning and memory by sirtuin 1

In the hippocampus, SIRT1 affects synaptic plasticity via a repressor complex containing the transcription factor YY, which regulates microRNA-134 (mIR-134). This brain specific microRNA regulates cAMP response binding protein (CREB) expression and brain-derived neurotrophic factor (BDNF) (Gao et al., 2010). These proteins are important for synapse formation and long-term potentiation. SIRT1 knockout mice have impaired hippocampal-dependent memory that is associated with decreased long-term potentiation in the CA1 region of the hippocampus (Gao et al., 2010).

Figure 3

Figure 3. Sirtuin1 and hypothalamic function

The hypothalamus regulates physiology and behavior by coordinating neuroendocrine responses that modulate appetite, temperature, circadian control and hormonal release to maintain homeostasis (Coppari, 2012). In the ventromedial hypothalamic nucleus, SIRT1 increases energy expenditure and protects against diet-induced obesity under fed high-fat diets (Ramadori et al., 2011; Ramadori et al., 2010). SIRT1 also regulates activity and body temperature in the dorsomedial and lateral hypothalamus (Satoh et al., 2010). In arcuate nucleus, SIRT1 modulates appetite, adaptive immunity and reward circuitry (Dietrich et al., 2010; Matarese et al., 2013). In the superschiasmatic nucleus of the hypothalamus, SIRT1 levels decrease with aging, affecting the activity pattern and circadian period. Overexpressing brain SIRT1 activates the transcription of BMAL and CLOCK proteins enabling animals to be protected from aging related changes to the central circadian clock (Chang and Guarente, 2013).

Figure 4

Figure 4. Major targets and mechanisms of SIRT1 in mouse models of neurodegenerative disease

Alzheimer’s disease (highlighted in red) In Alzheimer’s disease, SIRT1 has been shown to promote non-amyloidogenic APP processing pathway by decreasing levels of ROCK1 kinase (Qin et al., 2006). SIRT1 may also target the retinoic acid receptor β, which activates ADAM10 to facilitate processing of APP along a non-amyloidogenic pathway (Donmez et al., 2010). SIRT1 has also been shown to directly deacetylate tau in several tauopathy models enabling ubiquitin ligases to promote clearance of this protein (Cohen et al., 2011; Min et al., 2010). Parkinson’s disease (highlighted in blue) SIRT1 has been shown to deacetylate HSF, which induces transcription of molecular chaperones that promote protein folding (Donmez et al., 2012; Raynes et al., 2012; Westerheide et al., 2009). In addition to its effects on the heat shock response, SIRT1 may also function to regulate autophagy and mitophagy, which may affect α-synuclein toxicity in the context of PD (Sampaio-Marques et al., 2012; Wu et al., 2011). There is also evidence that PGC1α may be a relevant target in mouse models of PD (Mudo et al., 2012). Huntington’s disease (highlighted in green) Several different molecular mechanisms account for the protective effect of SIRT1 overexpression against mutant huntingtin toxicity (Jeong et al., 2012; Jiang et al., 2012). Mutant huntingtin protein was found to inhibit the enzymatic activity of SIRT1 during HD pathogenesis. One proposed mechanism is that SIRT1 deacetylates TORC1, facilitating BDNF transcription through CREB (Jeong et al., 2012). An alternate explanation for the protective effect of SIRT1 in HD mice was that this protein might maintain TrkB signaling and DARPP32 levels as HD progresses. Foxo3a deacetylation was another SIRT1 target implicated in promoting cell survival in the HD models (Jiang et al., 2012). Amyotrophic lateral sclerosis (highlighted in beige) The proposed mechanism for SIRT1’s activity in Amyotrophic lateral sclerosis parallels one of the pathways observed in PD. SIRT1 has been shown to deacetylate HSF1, which increases transcription of molecular chaperones including HSP70 and HSP25 that help to maintain intracellular protein homeostasis, reducing toxicity to motor neurons (Han et al., 2012; Raynes et al., 2012; van Ham et al., 2008; Westerheide et al., 2009). It has also been shown to affect mitochondrial biogenesis in cell culture models of ALS and this may be due to deacetylation of PGC1α (Wang et al.) Multiple sclerosis (highlighted in orange) In experimental autoimmune encephalitis (EAE), the mouse model for multiple sclerosis (MS), the mechanism of protection in whole animal models has not been completely elucidated. In adult neuronal precursor cells (NPCs), SIRT1 binds Hes1 under oxidative conditions, inhibiting Mash1 transcription and driving NPCs toward astroglial differentiation (Prozorovski et al., 2008) and increasing the oligodendrocyte population may help remyelinate lesions, reduce axonal damage or decrease astrogliosis. An alternate approach has identified increased BDNF and NAMPT as possible targets to explain neuroprotection due to SIRT1 overexpression in EAE (Nimmagadda et al., 2013).

Similar articles

Cited by

References

    1. Abe N, Uchida S, Otsuki K, Hobara T, Yamagata H, Higuchi F, Shibata T, Watanabe Y. Altered sirtuin deacetylase gene expression in patients with a mood disorder. J Psychiatr Res. 2011;45:1106–1112. - PubMed
    1. Adamec E, Vonsattel JP, Nixon RA. DNA strand breaks in Alzheimer’s disease. Brain Res. 1999;849:67–77. - PubMed
    1. Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G, Colombo L, Manzoni C, Salmona M, Caccia S, et al. The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1–42) peptide. J Neurochem. 2009;110:1445–1456. - PubMed
    1. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602–611. - PubMed
    1. Ardestani PM, Liang F. Sub-cellular localization, expression and functions of Sirt6 during the cell cycle in HeLa cells. Nucleus. 2012;3:442–451. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources